<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=utf-8"><meta name=Generator content="Microsoft Word 12 (filtered medium)"><style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
{font-family:"Open Sans";}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri","sans-serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
span.EmailStyle17
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:windowtext;
font-weight:normal;
font-style:normal;}
span.EmailStyle18
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-CA link=blue vlink=purple><div class=WordSection1><p class=MsoNormal><span style='color:#1F497D'>Hi all:<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>Below is a bunch of info from the Chair of PCCN Oakville /Mississauga.<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>This is one of the benefits of the networking via PCCN.<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>Read, click, digest, delete as you see fit.<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>Take care,<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>Glen<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p><div><div style='border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0cm 0cm 0cm'><p class=MsoNormal><b><span lang=EN-US style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'>From:</span></b><span lang=EN-US style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'> Walter Eadie [mailto:walter.eadie@cogeco.ca] <br><b>Sent:</b> August 13, 2018 3:44 PM<br><b>To:</b> PC Support Group<br><b>Subject:</b> Prostate Cancer Items for Information and Discussioin<o:p></o:p></span></p></div></div><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal style='background:white;vertical-align:baseline'><span style='font-size:12.0pt'>Hello everyone. As promised, here are links to a number of items of interest. Some I have seen on line and others you have sent to me (thank you).<o:p></o:p></span></p><p class=MsoNormal style='background:white;vertical-align:baseline'><span style='font-size:12.0pt'>We can discuss any of this if required at our meeting this Wednesday evening at Wellspring.<o:p></o:p></span></p><p class=MsoNormal style='background:white;vertical-align:baseline'><span style='font-size:12.0pt'><o:p> </o:p></span></p><p class=MsoNormal style='background:white;vertical-align:baseline'><span style='font-size:12.0pt'>1)<b><u><span style='color:black'> </span></u></b></span><b><span lang=EN-US style='font-size:12.0pt;color:black'>Online Androgen Deprivation Therapy Educational Program in<i> </i>Canada</span></b><span lang=EN-US style='font-size:12.0pt'> (see attachment 1). <i>Note: Murray Jans has taken this and can discuss if you are interested.</i><o:p></o:p></span></p><p class=MsoNormal style='background:white;vertical-align:baseline'><span lang=EN-US style='font-size:12.0pt;color:black'>A national, online educational program is now available for prostate cancer patients who are about to start or have been on androgen deprivation therapy (ADT). </span><span lang=EN-US><o:p></o:p></span></p><p class=MsoNormalCxSpMiddle style='margin-left:36.0pt;text-indent:-18.0pt;background:white;vertical-align:baseline'><span lang=EN-US style='font-size:12.0pt'>-</span><span lang=EN-US style='font-size:7.0pt;font-family:"Times New Roman","serif"'> </span><span lang=EN-US style='font-size:12.0pt;color:black'>This program is ideally for patients who are about to start ADT, but patients who have been on ADT are also welcome. Partners of patients on ADT are encouraged to attend, also.</span><span lang=EN-US style='font-size:12.0pt'> </span><span lang=EN-US><o:p></o:p></span></p><p class=MsoNormalCxSpMiddle style='margin-left:36.0pt;text-indent:-18.0pt;background:white;vertical-align:baseline'><span lang=EN-US style='font-size:12.0pt'>-</span><span lang=EN-US style='font-size:7.0pt;font-family:"Times New Roman","serif"'> </span><span lang=EN-US style='font-size:12.0pt;color:black'>Class structure: A single, <b>1.5 hour online webinar</b>. Sessions are <b>offered every 3 weeks</b> as an interactive, facilitated class via the GoToMeeting platform. Canadian patients will also receive a free copy of the book: "<i>Androgen Deprivation Therapy: An Essential Guide for Prostate Cancer Patients and Their Loved Ones.”</i></span><span lang=EN-US><o:p></o:p></span></p><p class=MsoNormalCxSpMiddle style='margin-left:36.0pt;text-indent:-18.0pt;background:white;vertical-align:baseline'><span lang=EN-US style='font-size:12.0pt'>-</span><span lang=EN-US style='font-size:7.0pt;font-family:"Times New Roman","serif"'> </span><span lang=EN-US style='font-size:12.0pt;color:black'>Upcoming sessions will be held on August 30<sup>th</sup> and September 19<sup>th</sup>, both at 3 pm Pacific time, and October 10<sup>th</sup> at 5 pm Pacific time. *<i>Space is limited.</i></span><span lang=EN-US style='font-size:12.0pt'> </span><span lang=EN-US><o:p></o:p></span></p><p class=MsoNormalCxSpMiddle style='margin-left:36.0pt;text-indent:-18.0pt;background:white;vertical-align:baseline'><span lang=EN-US style='font-size:12.0pt'>-</span><span lang=EN-US style='font-size:7.0pt;font-family:"Times New Roman","serif"'> </span><span lang=EN-US style='font-size:12.0pt;color:black'>How to register:</span><span lang=EN-US style='font-size:12.0pt'> <span style='color:black'>You can fill in a form on the home page of </span><u><span style='color:blue'><a href="http://www.lifeonadt.com/" target="_blank"><span style='color:#0563C1'>www.LifeOnADT.com</span></a></span></u><span style='color:black'> or send an email to </span><u><span style='color:blue'><a href="mailto:LifeOnADT@gmail.com" target="_blank"><span style='color:#0563C1'>LifeOnADT@gmail.com</span></a></span></u><span style='color:black'>.</span> </span><span lang=EN-US><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:12.0pt'><o:p> </o:p></span></p><p class=MsoNormal><span style='font-size:12.0pt'>2) <b>MRI vs. PSA Prostate Cancer Screening Study</b> (see attachment 2). You may have seen this in one of the Toronto newspapers<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:12.0pt'><o:p> </o:p></span></p><p class=MsoNormal><span style='font-size:12.0pt'>3) </span><b><span lang=EN-US style='font-size:12.0pt'>Pathway to Sex and Intimacy for Couples Affected by Prostate Cancer:</span></b><b><span lang=EN-US style='color:#333333'> </span></b><b><span lang=EN-US style='font-size:12.0pt;color:#333333'>Saturday, September 29, 2018</span></b><span lang=EN-US style='font-size:12.0pt'><o:p></o:p></span></p><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td width="100%" valign=top style='width:100.0%;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal><i><span style='color:#333333'>Prostate Cancer Pathways for Patients and Caregivers</span></i><span style='color:#333333'> is a new, free educational event and webcast series from Us TOO International. Please join us for our next <i>Pathways</i> event by attending in person, or <b>by watching the online webcast with live audio and video from the event</b>.</span><span style='font-family:"Open Sans";color:red;background:white'> </span><span style='font-family:"Open Sans";background:white'>The Englewood, NJ Event will Feature a Special Presentation on Sex and Intimacy Related to Prostate Cancer. </span><span style='color:#333333'><a href="https://www.mainstreamchicago.com/ustoo-pathways-new-jersey">https://www.mainstreamchicago.com/ustoo-pathways-new-jersey</a></span><o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><b><span style='font-size:12.0pt'>4) Here is a link to a prior webcast from Us TOO International – </span></b><span style='font-size:12.0pt'>lots of items of interest </span><span style='color:#141823'><a href="http://www.ustoo.org/Pathways-Seattle-Webcast">www.ustoo.org/Pathways-Seattle-Webcast</a>.</span><b><o:p></o:p></b></p><p class=MsoNormal><b><o:p> </o:p></b></p><p class=MsoNormal><b><span style='font-size:12.0pt'>5) DNA Testing for Prostate Cancer </span></b>(we will hear more about this at our October meeting)<o:p></o:p></p><p class=MsoNormal><span style='color:#333333'><a href="https://www.forbes.com/sites/victoriaforster/2018/06/11/new-100-genetic-test-identifies-men-who-have-vastly-increased-chance-of-developing-prostate-cancer/#15b82f913422">https://www.forbes.com/sites/victoriaforster/2018/06/11/new-100-genetic-test-identifies-men-who-have-vastly-increased-chance-of-developing-prostate-cancer/#15b82f913422</a><o:p></o:p></span></p><p class=MsoNormal><b><span style='color:#333333'><o:p> </o:p></span></b></p><p class=MsoNormal><b><span style='color:#333333'>6) </span></b><b><span style='font-size:12.0pt'>SpaceOar insert to reduce side-effects of Radiation Therapy </span></b><span style='color:#333333'><a href="https://www.rte.ie/news/health/2018/0808/983732-prostate-cancer/">https://www.rte.ie/news/health/2018/0808/983732-prostate-cancer/</a><o:p></o:p></span></p><p class=MsoNormal><b><span style='color:#333333'><o:p> </o:p></span></b></p><p class=MsoNormal><b><span style='color:#333333'><o:p> </o:p></span></b></p><p class=MsoNormal><span style='color:#333333'><o:p> </o:p></span></p><p class=MsoNormal><i><span style='color:#333333'><o:p> </o:p></span></i></p></td></tr><tr><td width="100%" valign=top style='width:100.0%;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal><i><span style='color:#333333'><o:p> </o:p></span></i></p></td></tr></table></div><p class=MsoNormal align=center style='text-align:center'><span lang=EN-US><o:p> </o:p></span></p><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td width="100%" valign=top style='width:100.0%;padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td style='padding:7.5pt 15.0pt 7.5pt 15.0pt'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'></td></tr></table></td></tr></table></td></tr></table></div><p class=MsoNormal><span lang=EN-US style='font-size:12.0pt'><o:p> </o:p></span></p><p class=MsoNormal><span style='font-size:12.0pt'><o:p> </o:p></span></p></div></body></html>